Philosophy of Care:
No two cancer patients are exactly alike, so the need and ability to highly customize radiation treatment requires disease-specific training and extensive experience. Minimizing the long-term side-effects of today's advanced treatments is also a major consideration. Dealing with the unique challenges inherent in each patient's social situation, individual goals of care, and tumor characteristics keeps me excited about my work as a member of the dedicated and experienced team of physicians, nurses, technicians and physicists at MedStar Georgetown.
Peter H. Ahn, MD, joined the medical staff of MedStar Georgetown University Hospital's Department of Radiation Oncology in 2017, after five years as a radiation oncologist and assistant professor with the University of Pennsylvania Health System. Previously, he was an assistant professor at Thomas Jefferson University and Hospital in Philadelphia. Fellowship-trained at MD Anderson Cancer Centerand board-certified in radiation oncology, Dr. Ahnhas extensive experience in treating cancers of the head and neck, skin (including melanoma), skull base, and brain using a variety of therapeutic approaches, including conventional and proton beam radiation therapies. He is nationally recognized by Castle Connolly's annual publication, "America's Top Doctors." Dr. Ahn's research has been funded by industry, private and public sources including NIH, and been published in peer-reviewed journals. A frequent guest lecturer and presenter, he is also a reviewer for multiple scientific and medical publications. Publications/Presentations Khalili S, Worrall DM, Brooks S, Morris SM, Farquhar D, Newman JG, Learned KO, Ahn PH, Craig J, Kennedy DW, O'Malley BW, Palmer JN, Adappa ND. Endoscopy versus imaging: Analysis of surveillance methods in sinonasal malignancy. Head and Neck. 2016. Ahn PH, Machtay M, Anne PR, Cognetti D, Keane WM, Wuthrick E, Dicker AP, Axelrod RS. Phase I trial using induction ciplatin, docetaxel, 5-FU and erlotinib followed by cisplatin, bevacizumab and erlotinib with concurrent radiotherapy for advanced head and neck cancer. American Journal of Clinical Oncology. 2016 Anamalayil SJ, Teo BKK, Lin A, Lustig RA, Ahn PH. Full-Neck Volumetric Modulated Arc Therapy versus Split-Field Intensity Modulated Radiation Therapy on Low Neck Structures. British Journal of Radiology, 2016. Ahn PH, Quon H, Mick R, O'Malley BW, Weinstein GS, Chalian A, Malloy K, Sollecito T,Greenberg M, McNulty S, Lin A, Zhu T, Finlay J, Cengel K, Livolsi V, Feldman M, Busch TM. Toxicities and Early Outcomes in Phase 1 Trial of Photodynamic Therapy for Premalignant and Early Stage Head and Neck Tumors. Oral Oncology. 2016 Wang P, Yin L, Song G, Ahn PH, Lin A, Gee J, Dolney D, Solberg TD, Maughan R, McDonough J, Teo BK. Quantitative Assessment of Anatomical Change Using a Virtual Proton Depth Radiograph (PDR). Journal of Applied Clinical Medical Physics. 2016 Ahn PH, Mitra N, Alonso-Basanta M, Adappa ND, Palmer JN, O'Malley Jr. BW, Rassekh CH,Chalian A, Cohen RB. Nodal Metastasis and Elective Nodal Level Treatment in Sinonasal Small Cell and Sinonasal Undifferentiated Carcinoma: A Surveillance, Epidemiology and End Results Analysis. British Journal of Radiology. 2016 Professional Memberships American Society Therapeutic Radiation Oncology (ASTRO)